October 7, 2025 | Uncategorized

Vensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture Partner

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

31

Exits by IPO or M&A